Recent Updates
Recently added Catalysts
RHEP Positive Sentiment

Regional Health Properties Reports Second Quarter 2026 Results

Key Takeaway: Regional Health Properties reported second quarter 2026 revenue of $24.4 million, a significant increase from $10.1 million in Q2 2025. The company achieved an adjusted EBITDA of $0.7 million, up from $56,000 last year. Portfolio occupancy improved to 74.9%, while pharmacy services contributed $9.6 million in revenue. Despite these gains, the company still recorded a net loss of $0.8 million.
Price reaction · baseline $1 (2026-08-18 close) · hit pre-market · clean, no other RHEP news in the window
day 0 close
0%
day 1
0%
day 3 · peak
+15%

Market Sentiment Analysis

POSITIVE FACTORS

  • Revenue increased significantly to $24.4 million.
  • Adjusted EBITDA improved to $0.7 million from $56,000.
  • Portfolio occupancy rose to 74.9%, an 870-basis-point improvement.
  • Pharmacy Services revenue reached $9.6 million.

CONCERNS & RISKS

  • GAAP net loss of $0.8 million, though improved from $1.5 million.
  • Net loss per share decreased but remains negative at $0.20.

Full Press Release Details

.Reported Second Quarter Revenue of $24.4 million Generated Adjusted EBITDA from Operations of $0.7 million Continued Execution of Integrated Healthcare Platform Strategy
ATLANTA, GA, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company,” “Regional,” “we,” “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB) (OTCQB: RHEPZ), a healthcare company that owns, operates and invests in healthcare real estate and operating businesses focused on long-term care, senior housing and pharmacy services, today announced its financial results for the second quarter ended June 30, 2026.
Second Quarter 2026 Financial Results
• Reported revenue of $24.4 million, compared with $10.1 million for the second quarter of 2025
• Reported GAAP net loss of $0.8 million, compared with GAAP net loss of $1.5 million for the second quarter of 2025
• Generated Adjusted EBITDA from operations of $0.7 million, compared with $56,000 for the second quarter of 2025
• Reported net loss attributable to common stockholders of $0.20 per share, compared with $0.68 per share for the second quarter of 2025
Second Quarter 2026 Business Highlights
• Pharmacy Services revenue was $9.6 million following the addition of the Pharmacy Services segment in connection with the SunLink merger
• Patient care revenues increased to $14.0 million, driven primarily by the transition of facilities to the Healthcare Services segment and higher census across the portfolio
• Portfolio occupancy was 74.9% at June 30, 2026 vs. 66.2% at June 30, 2025, an 870-basis-point improvement.
• Repurchased 5,000 shares of the Company’s 12.5% Series B Cumulative Redeemable Preferred Shares during the quarter at a discount to carrying value
• Continued to evaluate refinancing and liquidity alternatives, including potential refinancing of the Southland facility and other mortgage loans
Management Comments
Brent Morrison, Regional’s President, Chief Executive Officer and Chairman, commented, “Our strategy of selectively stepping back into the operations of our owned facilities continues to progress. Our operating partners are making meaningful progress streamlining facility operations, improving census and managing costs to generate stronger and more sustainable cash flow. Importantly, several of our operated facilities are now generating facility-level EBITDAR in excess of the lease payments we previously received as a landlord, demonstrating the potential economic value of our owner-operator strategy.”
Mr. Morrison continued, “Our priorities for the remainder of 2026 remain focused on improving facility-level margins, continuing to integrate and optimize our Pharmacy and DME businesses, and advancing refinancing initiatives. As operating performance improves, our objective is to convert that progress into stronger free cash flow while maintaining disciplined capital allocation. We believe these efforts can strengthen Regional’s financial profile, simplify our capital structure and create additional value for our common shareholders over time.”
Balance Sheet And Liquidity
As of June 30, 2026, the Company had $1.7 million of unrestricted cash and $2.8 million of restricted cash. As of June 30, 2026, the Company had $42.6 million of indebtedness, net of deferred financing costs and unamortized discounts. The Company continues to evaluate refinancing opportunities intended to improve liquidity, extend maturities and provide additional flexibility to execute its capital allocation strategy.

About Regional Health Properties, Inc.

Regional Health Properties, Inc. is a healthcare company that owns, operates and invests in healthcare real estate and operating businesses focused on long-term care, senior housing and pharmacy services. For more information, visit https://www.regionalhealthproperties.com.

Important Cautions Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “expects,” “intends,” “believes,” “anticipates,” “plans,” “likely,” “will,” “seeks,” “estimates” and variations of such words and similar expressions are intended to identify such forward-looking statements. This press release includes forward-looking statements that reflect the Company’s current views with respect to, among other things, its business, operations, financial performance, liquidity, capital resources, refinancing alternatives, facility operations, pharmacy operations, and future strategy.
Forward-looking statements, by their nature, involve estimates, projections, goals, forecasts and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those projected or contemplated by our forward-looking statements due to various factors, including, among others: the operating performance of our Healthcare Services and Pharmacy Services segments; our ability to collect patient, pharmacy and rent receivables; our dependence on the operating success of our tenants and managers; our ability to service our indebtedness and comply with covenants; the availability and cost of capital; our ability to refinance indebtedness, raise capital or complete asset sales on acceptable terms; changes in reimbursement rates and healthcare regulation; pharmacy reimbursement and claims-processing risk; labor costs, staffing availability and union-related matters; regulatory survey and compliance matters; inflation and interest rates; litigation and insurance costs; the relatively illiquid nature of real estate investments; and other factors discussed from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. These forward-looking statements speak only as of the date of this press release, and we expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein, except to the extent otherwise required by applicable law.
Company Contact
Brent Morrison, CFA
Chief Executive Officer & President
Regional Health Properties, Inc.
Tel 678-869-5116
Brent.morrison@regionalhealthproperties.com
REGIONAL HEALTH PROPERTIES, INC.
STATEMENT OF OPERATIONS
(in thousands)
Three Months Ended June 30,
2026 2025
(Unaudited)
Revenues:
Patient care revenues $ 14,001 $ 8,774
Rental revenues 801 1,283
Pharmacy revenues 9,640 —
Total revenues 24,442 10,057
Expenses:
Cost of goods sold 6,089 —
Patient care expense 10,654 7,184
Facility rent expense 247 149
Depreciation and amortization 757 403
General and administrative expense 6,696 2,429
Credit loss expense 215 400
Total expenses 24,658 10,565
Loss from operations (216 ) (508 )
Other expense:
Interest expense, net 567 615
Loss on disposal of assets 8 —
Other (income) expense, net — 326
Total other (income) expense, net 575 941
Net loss (791 ) (1,449 )
Deemed contribution related to Preferred Series B purchases 9 —
Net loss attributable to Regional Health Properties, Inc. common stockholders $ (782 ) $ (1,449 )
Net loss per share of common stock attributable to Regional Health Properties, Inc.:
Basic and Diluted $ (0.20 ) $ (0.68 )
Weighted average shares of common stock outstanding:
Basic and Diluted 3,928 2,143
REGIONAL HEALTH PROPERTIES, INC.
BALANCE SHEET
(in thousands)
6/30/2026 12/31/2025
(Unaudited)
ASSETS
Cash $ 1,728 $ 3,013
Restricted cash 2,052 1,631
Accounts receivable, net of allowances of $933 and $727 10,294 8,025
Inventory 1,520 1,354
Notes receivable 594 644
Prepaid expenses and other 1,532 1,623
Total current assets 17,720 16,290
Property and equipment, net 35,189 35,805
Assets held for sale, net 4,251 4,207
Restricted cash 796 1,420
Intangible assets 4,607 4,660
Other assets 3,815 3,842
Goodwill 1,585 1,585
Total assets $ 67,963 $ 67,809
LIABILITIES AND EQUITY
Accounts payable $ 7,337 $ 6,986
Accrued expenses 9,329 7,888
Other liabilities 1,982 867
Debt related to assets held for sale, net 3,072 3,001
Current portion of long term debt 5,366 5,414
Total current liabilities 27,086 24,156
Long-term debt, net - less current maturities 34,123 34,738
Operating lease obligation 2,276 2,325
Other liabilities 1,499 1,550
Total liabilities 64,984 62,769
'Preferred stock, Series D, no par values, 1,420 shares authorized; 1,405 shares issued and outstanding at June 30, 2026 and December 31, 2025. 4,691 4,691
Stockholders' equity:
Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 3,936 issued and 3,925 outstanding at June 30, 2026 and 3,946 issued and 3,935 outstanding at December 31, 2025. 67,465 67,296
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A, Series B and Series D); shares issued and outstanding designated separately
Preferred stock, Series A, no par value; 560 shares authorized, issued and outstanding at June 30, 2026 and December 31, 2025, with a redemption amount $426 at June 30, 2026 and December 31, 2025 426 426
Preferred stock, Series B, no par value; 2,812 shares authorized; 1,706 and 1,741 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively, with a redemption amount $14,100 and $14,382 at June 30, 2026 and December 31, 2025, respectively 14,091 14,382
Accumulated deficit (83,716 ) (81,777 )
Accumulated other comprehensive earnings 22 22
Total stockholders' equity (deficit) (1,712 ) 349
Total liabilities, Series D preferred stock and stockholders' equity (deficit) $ 67,963 $ 67,809
DEBT SUMMARY
(in thousands)
6/30/2026
Maturity Interest Rate Principal % of Principal Deferred financing costs Unamortized discount on bonds Net Carrying Value
Total Fixed Rate Debt 04/04/33 4.35 % 36,477 84.1 % (637 ) (98 ) 35,742
Total Floating Rate Debt 10/02/36 8.42 % 6,886 15.9 % (67 ) - 6,819
Total $ 43,363 100.0 % $ (704 ) $ (98 ) $ 42,561
REGIONAL HEALTH PROPERTIES, INC.
RECONCILIATION OF NET (LOSS) TO NON-GAAP FINANCIAL MEASURES
(in thousands)
Three Months Ended June 30,
2026 2025
(Unaudited)
Net loss $ (791 ) $ (1,449 )
Depreciation and amortization 757 403
Interest expense, net 567 615
EBITDA 533 (431 )
Amortization of employee stock compensation 73 25
Merger and other one-time costs — 357
Tail insurance on legacy facilities — 19
Other one-time income 143 86
Adjusted EBITDA from operations $ 749 $ 56

Frequently Asked Questions

What was Regional Health Properties' revenue for Q2 2026?

The revenue for Q2 2026 was $24.4 million.

How much did adjusted EBITDA increase in Q2 2026?

Adjusted EBITDA increased to $0.7 million from $56,000.

What was the net loss for Regional Health Properties in Q2 2026?

The net loss for Q2 2026 was $0.8 million.

What contributed to the revenue increase in Q2 2026?

The increase was driven by higher patient care revenues and pharmacy services.

Last updated: Aug 19, 2026